Repligen Corporation

NASDAQ: RGEN · Real-Time Price · USD
118.24
-2.21 (-1.83%)
At close: May 23, 2025, 3:59 PM
122.00
3.18%
After-hours: May 23, 2025, 04:44 PM EDT

Repligen Statistics

Share Statistics

Repligen has 56.18M shares outstanding. The number of shares has increased by 0.27% in one year.

Shares Outstanding 56.18M
Shares Change (YoY) 0.27%
Shares Change (QoQ) 0%
Owned by Institutions (%) 99.99%
Shares Floating n/a
Failed to Deliver (FTD) Shares 2,044
FTD / Avg. Volume 0.25%

Short Selling Information

The latest short interest is 3.44M, so 6.12% of the outstanding shares have been sold short.

Short Interest 3.44M
Short % of Shares Out 6.12%
Short % of Float 8.25%
Short Ratio (days to cover) 3.75

Valuation Ratios

The PE ratio is -315.57 and the forward PE ratio is 55.25. Repligen's PEG ratio is 1.84.

PE Ratio -315.57
Forward PE 55.25
PS Ratio 12.69
Forward PS 5.4
PB Ratio 4.08
P/FCF Ratio 56.51
PEG Ratio 1.84
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Repligen.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.35.

Current Ratio 8.41
Quick Ratio 8.41
Debt / Equity 0.35
Debt / EBITDA 8.36
Debt / FCF 4.82
Interest Coverage -1.56

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $356,827.33
Profits Per Employee $-14,349.83
Employee Count 1,778
Asset Turnover 0.22
Inventory Turnover n/a

Taxes

Income Tax -1.52M
Effective Tax Rate 5.63%

Stock Price Statistics

The stock price has increased by -24.16% in the last 52 weeks. The beta is 1.21, so Repligen's price volatility has been higher than the market average.

Beta 1.21
52-Week Price Change -24.16%
50-Day Moving Average 132.46
200-Day Moving Average 145.07
Relative Strength Index (RSI) 40.03
Average Volume (20 Days) 833,483

Income Statement

In the last 12 months, Repligen had revenue of 634.44M and earned -25.51M in profits. Earnings per share was -0.46.

Revenue 634.44M
Gross Profit 274.64M
Operating Income -35.11M
Net Income -25.51M
EBITDA 82.1M
EBIT -6.3M
Earnings Per Share (EPS) -0.46
Full Income Statement

Balance Sheet

The company has 757.36M in cash and 686.25M in debt, giving a net cash position of 71.11M.

Cash & Cash Equivalents 757.36M
Total Debt 686.25M
Net Cash 71.11M
Retained Earnings n/a
Total Assets 2.85B
Working Capital 880.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 175.39M and capital expenditures -32.91M, giving a free cash flow of 142.49M.

Operating Cash Flow 175.39M
Capital Expenditures -32.91M
Free Cash Flow 142.49M
FCF Per Share 2.55
Full Cash Flow Statement

Margins

Gross margin is 43.29%, with operating and profit margins of -5.53% and -4.02%.

Gross Margin 43.29%
Operating Margin -5.53%
Pretax Margin -4.26%
Profit Margin -4.02%
EBITDA Margin 12.94%
EBIT Margin -5.53%
FCF Margin 22.46%

Dividends & Yields

RGEN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RGEN is $180, which is 49.5% higher than the current price. The consensus rating is "Buy".

Price Target $180
Price Target Difference 49.5%
Analyst Consensus Buy
Analyst Count 12
Stock Forecasts

Scores

Altman Z-Score 6.34
Piotroski F-Score 5